{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:51:31Z","timestamp":1787637091628,"version":"build-2736575974"},"reference-count":39,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2006-3858"],"award-info":[{"award-number":["2006-3858"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2009-4250"],"award-info":[{"award-number":["2009-4250"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019032","name":"Uppsala-\u00d6rebro Regional Research Council","doi-asserted-by":"crossref","award":["RFR-10324"],"award-info":[{"award-number":["RFR-10324"]}],"id":[{"id":"10.13039\/100019032","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish government"},{"name":"\u00d6sterg\u00f6tland County Council"},{"name":"Research Council"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2024,11,27]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate if postnatal treatment with betamethasone in extremely preterm infants was associated with neurodevelopmental impairment (NDI) at 6.5 years of age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Prospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Extremely Preterm Infants in Sweden Study (gestational age &lt;27 weeks, born 2004\u20132007).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>428 children born extremely preterm were assessed at 6.5 years of age, 115 treated with betamethasone and 313 not treated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>NDI at 6.5 years of age. Evaluation at 6.5 years included cognitive testing with the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV), neurological examination and a medical record review.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Exposure<\/jats:title>\n                  <jats:p>Treatment with postnatal betamethasone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome<\/jats:title>\n                  <jats:p>Moderate to severe NDI at 6.5 years of age, defined as a composite including cerebral palsy, and\/or impairment in cognition, hearing and vision.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Moderate to severe NDI was more prevalent in children treated with postnatal betamethasone (49% treated vs 26% not treated, p&lt;0.001). Betamethasone-treated children had worse cognitive development with mean WISC-IV score of 75 (SD 13.7) vs 87 (SD 14.0, p&lt;0.001). The effect was dose dependent: 1.35 mg\/kg vs 1.0 mg\/kg (p=0.01) in betamethasone-treated children with moderate to severe versus no or mild NDI, respectively. The differences remained after adjustment for potential confounders with logistic regression (adjusted OR (aOR) 1.80, 95% CI 1.14 to 3.21). The difference in NDI also remained after propensity score matching, with crude OR 2.82 (95% CI 1.42 to 5.61, p=0.003) and aOR 2.17 (95% CI 1.07 to 4.69, p=0.04).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Postnatal treatment with betamethasone is associated with increased risk of NDI at 6.5 years.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2024-327360","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:02:56Z","timestamp":1734516176000},"page":"382-387","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Postnatal betamethasone treatment in extremely preterm infants and risk of neurodevelopmental impairment: a cohort study"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9311-8285","authenticated-orcid":false,"given":"Linn","family":"L\u00f6fberg","sequence":"first","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Crown Princess Victoria Children's Hospital, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2194-2374","authenticated-orcid":false,"given":"Fredrik","family":"Serenius","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3498-6069","authenticated-orcid":false,"given":"Lena","family":"Hellstrom-Westas","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4209-563X","authenticated-orcid":false,"given":"Elisabeth","family":"Olhager","sequence":"additional","affiliation":[{"name":"Pediatrics, Institution of Clinical Sciences, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-6883","authenticated-orcid":false,"given":"David","family":"Ley","sequence":"additional","affiliation":[{"name":"Pediatrics, Institution of Clinical Sciences, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0175-1617","authenticated-orcid":false,"given":"Aijaz","family":"Farooqi","sequence":"additional","affiliation":[{"name":"Pediatrics, Department of Clinical Sciences, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1528-4563","authenticated-orcid":false,"given":"Olof","family":"Stephansson","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Department of Medicine\u2013Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-8294","authenticated-orcid":false,"given":"Thomas","family":"Abrahamsson","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Crown Princess Victoria Children's Hospital, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"2025090503345664000_110.4.382.1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2016.1210"},{"key":"2025090503345664000_110.4.382.2","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14693"},{"key":"2025090503345664000_110.4.382.3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.5323"},{"key":"2025090503345664000_110.4.382.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1039","article-title":"Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study","volume":"356","author":"Travers","year":"2017","journal-title":"BMJ"},{"key":"2025090503345664000_110.4.382.5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.2.330"},{"key":"2025090503345664000_110.4.382.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.6.1425"},{"key":"2025090503345664000_110.4.382.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(09)90024-5"},{"key":"2025090503345664000_110.4.382.8","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1752653"},{"key":"2025090503345664000_110.4.382.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.12.013"},{"key":"2025090503345664000_110.4.382.10","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.107801"},{"key":"2025090503345664000_110.4.382.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910143411604"},{"key":"2025090503345664000_110.4.382.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1994.tb00822.x"},{"key":"2025090503345664000_110.4.382.13","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2008.194"},{"key":"2025090503345664000_110.4.382.14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.15406\/jpnc.2018.08.00330","article-title":"Rescue therapy with betamethasone in preterm infants (day of life>14) at high risk for bronchopulmonary dysplasia to assist weaning from ventilator support: a case series","volume":"8","author":"Sims","year":"2018","journal-title":"JPNC"},{"key":"2025090503345664000_110.4.382.15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00431-023-05319-z","article-title":"Neurodevelopment at 24 months corrected age in extremely preterm infants treated with dexamethasone alternatives during the late postnatal period: a cohort study","volume":"183","author":"Melan","year":"2024","journal-title":"Eur J Pediatr"},{"key":"2025090503345664000_110.4.382.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.771"},{"key":"2025090503345664000_110.4.382.17","doi-asserted-by":"crossref","unstructured":"Wechsler D . Wechsler Intelligence Scale for Children\u2013Fourth Edition (WISC-IV). San Antonio, TX: The Psychological Corporation, 2003.","DOI":"10.1037\/t15174-000"},{"key":"2025090503345664000_110.4.382.18","doi-asserted-by":"publisher","DOI":"10.1017\/S001216220500112X"},{"key":"2025090503345664000_110.4.382.19","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000934"},{"key":"2025090503345664000_110.4.382.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.01.052"},{"key":"2025090503345664000_110.4.382.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(05)80189-5"},{"key":"2025090503345664000_110.4.382.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2025090503345664000_110.4.382.23","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.991"},{"key":"2025090503345664000_110.4.382.24","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197801000-00001"},{"key":"2025090503345664000_110.4.382.25","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.2011060"},{"key":"2025090503345664000_110.4.382.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-018-0071-3"},{"key":"2025090503345664000_110.4.382.27","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12972"},{"key":"2025090503345664000_110.4.382.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2020.05.013"},{"key":"2025090503345664000_110.4.382.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-019-03339-2"},{"key":"2025090503345664000_110.4.382.30","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.14323"},{"key":"2025090503345664000_110.4.382.31","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.11.1512"},{"key":"2025090503345664000_110.4.382.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032089"},{"key":"2025090503345664000_110.4.382.33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1818"},{"key":"2025090503345664000_110.4.382.34","article-title":"Late (\u2265 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"11","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090503345664000_110.4.382.35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0956"},{"key":"2025090503345664000_110.4.382.36","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70294-1"},{"key":"2025090503345664000_110.4.382.37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1354"},{"key":"2025090503345664000_110.4.382.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.10.083"},{"key":"2025090503345664000_110.4.382.39","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.244"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2024-327360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T10:35:06Z","timestamp":1757068506000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2024-327360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,6,19]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/archdischild-2024-327360"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2024-327360","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}